Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$49.9 - $57.32 $74,001 - $85,005
1,483 Added 38.03%
5,383 $282,000
Q2 2022

Aug 19, 2022

BUY
$49.62 - $58.13 $8,435 - $9,882
170 Added 4.56%
3,900 $216,000
Q1 2022

May 13, 2022

BUY
$48.27 - $65.25 $180,047 - $243,382
3,730 New
3,730 $208,000
Q1 2020

May 15, 2020

SELL
$34.75 - $45.85 $426,069 - $562,166
-12,261 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.66 - $41.78 $449,488 - $512,264
12,261 New
12,261 $498,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.11B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.